Bevacizumab better for tumor imaging than Gold Standard Imaging

A new compound, Cu-64 labeled bevacizumab is claimed to be better than FDG which is considered gold standard for PET imaging. Bevacizumab, an anticancer agent is an antibody that targets vascular endothelial growth factor (VEGF), a signaling protein involved in angiogenesis. Follow the link below for details.
For Tumor Detection Bevacizumab Better Than Gold Standard Imaging

Indian Institute of Science celebrates Centenary shortly!

The advanced science research institute of India, Indian Institute of Science (IISc) at Bangalore seems preparing well for centenary celebration planned to be held this December.
Click here for an interview with the present director Prof. P. Balaram published by "Outlook India" and here for some history.
My fondness to this Institute remains even today as I remember in my early high school days when I went for morning jogs in the lush green premises of IISc. To gain entry (as my house was situated just outside the campus), I had to convince the security guards about the sole purpose of my visit is just to hike or jog. Occasionally, I evaded the guards sight and considered myself lucky to get in. It was in those times, that the scientific spirits rose seeing those buildings on the way where advanced scientific research was known to be conducted. Taking in the fresh air while jogging, it is hard to forget the number of times that I dreamt of working in any of those research buildings. Till today, those yet-to-be-accomplished dream stays alive!

My article gets quoted!

Glad to know that my article published in the journal 'Molecular Imaging and Biology' is quoted in the "Angiogenesis weekly" of "NewsRx", reports the web news portal "Pharmacy Choice". Click here for details.

SNM releases new fact sheet on breast cancer and molecular imaging

Keeping up the inspirational momentum, the SNM promotes the importance of research on molecular imaging by releasing a new fact sheet. It lists out the power of molecular imaging as

• Diagnose cancer early on—at its most curable stage;
• Create a portrait of what cells are doing and how they function over time;
• Eliminate the need for unnecessary exploratory surgery or multiple surgeries;
• Provide a painless and cost-effective alternative to more expensive—and less accurate—diagnostic tests;
• Confirm and treat suspected recurrent cancers;
• Monitor an individual's response to treatment and make adjustments as necessary;
• Equip physicians and individuals with information to make informed decisions about the best courses of action.

Well, these points should suffice the persistence for MI research. For details click here

Latest News - Fullerene Traps Longest Metal-Metal Bond

Here is a molecule having a potential as a new molecular imaging contrast agent. Read this for more.
Chemical & Engineering News: Latest News - Fullerene Traps Longest Metal-Metal Bond

Molecular Imaging: The Future of Modern Medicine

In the recently concluded Society of Nuclear Medicine meeting, molecular imaging research was considered as one of the forefront research area in modern medicine. Various research topics were discussed in the Molecular imaging summit organized at the same juncture. Click below for details
Molecular Imaging: The Future of Modern Medicine

New PET-Probe Allows Imaging of Immune System

"The probe is based on a fundamental cell biochemical pathway called the DNA salvage pathway, which acts as a sort of recycling mechanism that helps with DNA replication and repair. All cells use this biochemical pathway to different degrees. But in lymphocytes and macrophages, the cells of the immune system that initiate immune response, the pathway is activated at very high levels. Because of that, the probe accumulates at high levels in those cells, said the study's senior author, Dr. Owen Witte, a researcher at UCLA's Jonsson Cancer Center and a Howard Hughes Medical Institute investigator. " Click below for more
New PET-Probe Allows Imaging of Immune System
Researchers create new PET-scan probe

CORRECTING and REPLACING Cancer Detected Earlier, Faster, with New Medical Imaging

Here is a novel way of identifying individual cancer cells in vivo using a miniaturized micro (endo) scope called "Cellvizio GI".
"Not only did the researchers see fluorescent patches, they could make out the individual cancerous cells. That fine resolution could allow doctors to pick up the earliest possible cancers. Contag said it could also become a useful research tool for studying the small number of cancer stem cells that are thought to establish the eventual tumor. "
Click below for the details.

CORRECTING and REPLACING Cancer Detected Earlier, Faster, with New Medical Imaging, Stanford Study Finds

Innovative molecular imaging center gets five-year, $10 million renewal grant

Recently a $10 million grant from NCI has been awarded to Washington University School of Medicine in St. Louis for cancer imaging. For details click below.
Innovative molecular imaging center gets five-year, $10 million renewal grant